Calumet, Inc.

Basic Materials · Specialty Chemicals

53.90$ -1.0% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Income Statement

Calumet, Inc. (CLMT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 1,445 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement CLMT
Line item	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	LTM
Revenue	967	947	937	1,031	1,097	1,027	751	946	954	848	851	897	930	775	693	454	568	554	600	807	875	866	1,098	1,424	1,165	1,000	1,037	1,018	1,149	977	1,134	1,134	1,100	950	994	1,027	1,078	1,039	1,030	1,445	4,591
Cost of Revenue	856	866	798	871	946	899	637	822	849	752	715	790	812	684	669	395	552	532	642	788	742	833	1,065	1,280	1,026	965	941	946	888	955	1,070	1,070	1,096	866	1,075	1,070	704	1,042	1,117	1,427	4,290
Gross Profit	110	81	140	160	152	128	113	123	104	96	136	107	118	91	24	59	17	22	-42	19	133	33	33	144	139	35	97	72	262	22	64	64	4.9	84	-81	-44	374	-3.0	-88	18	302
Research & Development	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Selling, General & Administrative	70	73	72	75	78	64	71	65	67	57	71	69	61	58	20	27	30	42	37	30	31	54	33	23	43	43	37	26	40	29	38	38	40	45	12	41	31	39	66	39	176
Total Operating Expenses	100	106	107	109	117	117	72	80	83	79	91	86	81	86	48	36	47	62	65	53	40	71	50	48	57	62	54	46	49	35	58	58	62	61	-33	57	51	60	84	58	253
Operating Income	9.9	-28	32	52	35	32	41	44	22	16	34	4.7	33	4.4	-24	23	-31	-40	-107	-34	93	-39	-17	96	82	-27	43	25	213	-13	6.2	6.2	-57	23	-49	-101	323	-63	-171	-40	48
Interest Expense	45	44	44	45	47	47	45	38	38	35	32	33	34	35	29	31	33	33	34	37	38	40	52	43	42	40	49	56	59	58	57	57	58	61	59	53	54	51	51	52	208
Pre-Tax Income	-41	-80	-6.3	8.7	-24	-26	-3.1	-50	-16	19	16	-17	-4.1	-39	-14	3.8	-56	-82	-146	-78	52	-87	-95	-15	16	-75	19	-22	100	-46	-39	-39	-100	-41	-162	-148	272	-89	-338	-117	-272
Income Tax Expense	-7.6	-0.6	-0.1	-0.9	-0.1	-0.1	-0.2	0.8	0.4	-0.3	-0.1	0.3	0.5	-0.2	0.5	0.2	0.1	0.3	0.2	0.9	0.4	-1.7	0.7	0.6	1.5	0.6	0.5	0.4	0.5	0.2	0.5	0.5	0.7	-0.6	0.4	0.2	-41	-52	-21	-21	-135
Net Income	-33	-80	-6.2	8.8	-24	-24	-4.8	-52	-17	18	16	-17	-4.6	-39	-14	3.5	-55	-82	-146	-78	52	-87	-96	-15	16	-70	19	-22	100	-65	-38	-38	-101	-41	-162	-148	313	-37	-317	-96	-137
EBITDA	59	16	77	89	79	77	68	19	52	83	77	44	57	24	46	30	3.3	-23	-76	-11	121	-18	-7.1	58	88	-4.4	106	59	203	12	64	64	3.1	33	-56	-47	344	6.3	-348	22	25

LTM = last twelve months (sum of the four most recent quarters).

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Income Statement

Cookie settings